Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
出版年份 2019 全文链接
标题
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
作者
关键词
-
出版物
Cancers
Volume 11, Issue 10, Pages 1614
出版商
MDPI AG
发表日期
2019-10-23
DOI
10.3390/cancers11101614
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples
- (2019) Clément Morgat et al. PLoS One
- Therapeutic Potential of a Novel αvβ3 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type
- (2019) Billy Hill et al. Cancers
- Molecular Imaging and Theranostics—A Multidisciplinary Approach
- (2019) Andrea Farolfi et al. SEMINARS IN NUCLEAR MEDICINE
- Development and Evaluation of an 18F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression
- (2019) Diana Brickute et al. MOLECULAR PHARMACEUTICS
- Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading
- (2019) Jeremy Force et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy
- (2019) Adriana V.F. Massicano et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
- (2018) Farrokh Dehdashti et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- 18F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study
- (2018) Jiang Wu et al. JOURNAL OF NUCLEAR MEDICINE
- Sensitivity and Isoform Specificity of18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer
- (2018) Kelley Salem et al. JOURNAL OF NUCLEAR MEDICINE
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
- (2018) Sonia Pernas et al. LANCET ONCOLOGY
- Comparison of [99mTc]3PRGD2 Imaging and [18F]FDG PET/CT in Breast Cancer and Expression of Integrin αvβ3 in Breast Cancer Vascular Endothelial Cells
- (2018) Zhenying Chen et al. MOLECULAR IMAGING AND BIOLOGY
- 68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
- (2018) Jingjing Zhang et al. Theranostics
- Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
- (2018) T. Tegnebratt et al. EJNMMI Research
- 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer
- (2018) Jie Zang et al. CLINICAL NUCLEAR MEDICINE
- 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
- (2018) Frederike Bensch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pretreatment PET/CT imaging of angiogenesis based on 18F-RGD tracer uptake may predict antiangiogenic response
- (2018) Li Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET Imaging of Receptor Tyrosine Kinases in Cancer
- (2018) Weijun Wei et al. MOLECULAR CANCER THERAPEUTICS
- Impact of phosphorylated insulin‑like growth factor‑1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy
- (2018) Liang Li et al. Experimental and Therapeutic Medicine
- PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma
- (2018) Tibor Vag et al. EJNMMI Research
- Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma
- (2018) Sven H. Hausner et al. CLINICAL CANCER RESEARCH
- Peptide-based PET quantifies target engagement of PD-L1 therapeutics
- (2018) Dhiraj Kumar et al. JOURNAL OF CLINICAL INVESTIGATION
- [99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of αvβ3 Integrin: Synthesis, Structure–Activity and Pharmacokinetic Studies
- (2018) Cristina Bolzati et al. JOURNAL OF MEDICINAL CHEMISTRY
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- Integrating molecular nuclear imaging in clinical research to improve anticancer therapy
- (2018) Elisabeth G. E. de Vries et al. Nature Reviews Clinical Oncology
- PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer
- (2018) Sandra Heskamp et al. Cancer Immunology Research
- Mechanisms of Regulation of the Chemokine-Receptor Network
- (2017) Martin Stone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
- (2017) Gary A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
- (2017) Michel Paquette et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
- (2017) Clément Morgat et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor Uptake of64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
- (2017) Joanne E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Chemokine receptor – Directed imaging and therapy
- (2017) Andreas K. Buck et al. METHODS
- Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation
- (2017) Zhengyuan Zhou et al. MOLECULAR IMAGING AND BIOLOGY
- NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice
- (2017) Aikaterini Kaloudi et al. MOLECULES
- Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
- (2017) Krzysztof M. Zak et al. STRUCTURE
- Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
- (2017) Simona Camorani et al. Scientific Reports
- Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
- (2017) Simona Camorani et al. Theranostics
- A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
- (2017) Sara Santagata et al. Scientific Reports
- Gold Nanoclusters Doped with 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis
- (2016) Yongfeng Zhao et al. ACS Nano
- PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
- (2016) Wojciech G. Lesniak et al. BIOCONJUGATE CHEMISTRY
- 18 F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
- (2016) Yingbing Wang et al. CLINICAL CANCER RESEARCH
- Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
- (2016) G. Vaidyanathan et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
- (2016) A. M. Fowler et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga/ 177 Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
- (2016) Simone U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- (2016) B. Behnam Azad et al. JOURNAL OF NUCLEAR MEDICINE
- First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers
- (2016) T. Vag et al. JOURNAL OF NUCLEAR MEDICINE
- Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
- (2016) E. Wehrenberg-Klee et al. JOURNAL OF NUCLEAR MEDICINE
- Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
- (2016) Berthold A. Nock et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical Translation of a Dual Integrin α v β 3 – and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, 68 Ga-BBN-RGD
- (2016) Jingjing Zhang et al. JOURNAL OF NUCLEAR MEDICINE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Molecular imaging using PET and SPECT for identification of breast cancer subtypes
- (2016) Hao Liu et al. NUCLEAR MEDICINE COMMUNICATIONS
- A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
- (2016) Samit Chatterjee et al. Oncotarget
- Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
- (2016) Christian Stoykow et al. Theranostics
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
- (2016) Haojun Chen et al. Theranostics
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
- (2016) Jens Sörensen et al. Theranostics
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
- (2015) Z. Sun et al. CANCER RESEARCH
- Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
- (2015) S. Heskamp et al. CANCER RESEARCH
- Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast Cancer
- (2015) Anders Josefsson et al. CANCER RESEARCH
- Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT
- (2015) Theodosia Maina et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron emission tomography of tumour [18F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
- (2015) Michel van Kruchten et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer
- (2015) S. U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer
- (2015) A. Arulappu et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical significance of the integrin α6β4 in human malignancies
- (2015) Rachel L Stewart et al. LABORATORY INVESTIGATION
- Phase 1 Evaluation of [64Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors
- (2015) A. Craig Lockhart et al. MOLECULAR IMAGING AND BIOLOGY
- Synthesis and in Vitro and in Vivo Evaluation of an 18F-Labeled Neuropeptide Y Analogue for Imaging of Breast Cancer by PET
- (2015) Sven Hofmann et al. MOLECULAR PHARMACEUTICS
- Molecular imaging using PET for breast cancer
- (2015) Hiroaki Kurihara et al. Breast Cancer
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- Longitudinal Noninvasive Imaging of Progesterone Receptor as a Predictive Biomarker of Tumor Responsiveness to Estrogen Deprivation Therapy
- (2014) S. R. Chan et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: HER3 Targeted Therapy
- (2014) K. Gala et al. CLINICAL CANCER RESEARCH
- Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT
- (2014) Hai-Jeon Yoon et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cutting Edge: IFN- Enables APC to Promote Memory Th17 and Abate Th1 Cell Development
- (2014) I. Kryczek et al. JOURNAL OF IMMUNOLOGY
- 18F-FPPRGD2 PET/CT: Pilot Phase Evaluation of Breast Cancer Patients
- (2014) Andrei Iagaru et al. RADIOLOGY
- The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
- (2014) M. Isabel Palacios-Arreola et al. Journal of Immunology Research
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer
- (2013) M. L. Gemignani et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET
- (2013) J. E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Progesterone receptor targeting with radiolabelled steroids: An approach in predicting breast cancer response to therapy
- (2013) Susana Cunha et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Assessment of the Novel Estrogen Receptor PET Tracer 4-Fluoro-11β-methoxy-16α-[18F]fluoroestradiol (4FMFES) by PET Imaging in a Breast Cancer Murine Model
- (2013) Michel Paquette et al. MOLECULAR IMAGING AND BIOLOGY
- Novel Methods and Tracers for Breast Cancer Imaging
- (2013) Hannah M. Linden et al. SEMINARS IN NUCLEAR MEDICINE
- Molecular Imaging of Chemokine Receptor CXCR4
- (2013) Ido. D. Weiss et al. Theranostics
- Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16 ,17 -[(R)-(1'- -furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
- (2012) F. Dehdashti et al. JOURNAL OF NUCLEAR MEDICINE
- Optimization of IGF-1R SPECT/CT Imaging Using 111In-Labeled F(ab′)2 and Fab Fragments of the Monoclonal Antibody R1507
- (2012) Sandra Heskamp et al. MOLECULAR PHARMACEUTICS
- The Neuropeptide Y Y1 Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts
- (2012) Martin Memminger et al. PLoS One
- Integrin Targeted Imaging and Therapy
- (2012) Xiaoyuan Chen Theranostics
- PET Imaging of Integrin αVβ3 Expression
- (2012) Ambros J. Beer et al. Theranostics
- Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression
- (2011) Young-Hwa Soung et al. BMB Reports
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- (2011) Aoife J. Lowery et al. BREAST CANCER RESEARCH AND TREATMENT
- SPECT-CT and PET-CT in Oncology - An Overview
- (2011) Sandip Basu et al. Current Medical Imaging Reviews
- Evaluation of 177Lu-DOTA-sst2 Antagonist Versus 177Lu-DOTA-sst2 Agonist Binding in Human Cancers In Vitro
- (2011) R. Cescato et al. JOURNAL OF NUCLEAR MEDICINE
- Breast-Cancer Diagnosis by Neuropeptide Y Analogues: From Synthesis to Clinical Application
- (2010) Irfan U. Khan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
- (2010) Lyndsay V. Rhodes et al. CANCER RESEARCH
- Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
- (2010) S. Nimmagadda et al. CANCER RESEARCH
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- PET/CT in cancer research: from preclinical to clinical applications
- (2010) S. Del Vecchio et al. Contrast Media & Molecular Imaging
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular imaging of breast cancer
- (2009) T.H. Oude Munnink et al. BREAST
- Imaging of v 3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with v 5
- (2009) A. Zannetti et al. CLINICAL CANCER RESEARCH
- PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
- (2008) Farrokh Dehdashti et al. BREAST CANCER RESEARCH AND TREATMENT
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
- (2008) L. M. Peterson et al. JOURNAL OF NUCLEAR MEDICINE
- Assessment of Human Biodistribution and Dosimetry of 4-Fluoro-11 -Methoxy-16 -18F-Fluoroestradiol Using Serial Whole-Body PET/CT
- (2008) J.-M. Beauregard et al. JOURNAL OF NUCLEAR MEDICINE
- Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients
- (2008) L. M. Kenny et al. JOURNAL OF NUCLEAR MEDICINE
- Patterns of v 3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PET
- (2008) A. J. Beer et al. JOURNAL OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now